PT  - JOURNAL ARTICLE
AU  - Sarah Louise Johnston
AU  - Rob Hollingsworth
TI  - Immunoglobulin therapy
AID  - 10.7861/clinmedicine.16-6-576
DP  - 2016 Dec 01
TA  - Clinical Medicine
PG  - 576--579
VI  - 16
IP  - 6
4099  - http://www.rcpjournals.org/content/16/6/576.short
4100  - http://www.rcpjournals.org/content/16/6/576.full
SO  - Clin Med2016 Dec 01; 16
AB  - Immunoglobulin is an expensive blood product of potentially limited supply used in a wide variety of medical conditions, across a number of specialties. Historically, immunoglobulin has been associated with transmission of blood borne infection (eg hepatitis C). Immunoglobulin use needs to be carefully considered, appropriately prescribed and recorded. The Department of Health, in conjunction with relevant stakeholders, has established a demand management programme to secure immunoglobulin supplies for patients most in need of treatment and to limit use for indications where evidence is lacking.